Unpopular Choices Ahead For Pharma As France Wrestles With Spending Bill

 
• By Francesca Bruce
  
A French bill on social security spending for 2026 is likely to have a big impact on pharma. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Health Technology Assessment